Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ocular Therapeutix, Inc.(OCUL) | 1,190,071 | 1,111,071 | -79,000 | $10.35M | $9.49M | 9.55% | -$865.1K |
| Insmed Incorporated(INSM) | 107,500 | 104,800 | -2,700 | $7.85M | $7.24M | 7.28% | -$612.1K |
| Tourmaline Bio Inc | 332,095 | 351,842 | +19,747 | $8.54M | $7.14M | 7.18% | -$1.40M |
| Crinetics Pharmaceuticals In | 131,700 | 122,900 | -8,800 | $6.73M | $6.28M | 6.32% | -$446.0K |
| Enliven Therapeutics Inc | 296,368 | 267,368 | -29,000 | $7.57M | $6.02M | 6.05% | -$1.55M |
| Whitehawk Therapeutics, Inc.(WHWK) | 1,849,402 | 1,849,402 | 0 | $3.81M | $5.83M | 5.87% | +$2.03M |
| Praxis Precision Medicines, Inc.(PRAX) | 57,500 | 67,500 | +10,000 | $3.31M | $5.19M | 5.23% | +$1.89M |
| Revolution Medicines, Inc.(RVMD) | 108,000 | 111,700 | +3,700 | $4.90M | $4.89M | 4.92% | -$12.0K |
| argenx SEADR(ARGX) | 5,900 | 6,910 | +1,010 | $3.20M | $4.25M | 4.28% | +$1.05M |
| Vaxcyte, Inc.(PCVX) | 135,400 | 45,000 | -90,400 | $15.47M | $3.68M | 3.71% | -$11.79M |
| Trevi Therapeutics, Inc.(TRVI) | 290,500 | 771,958 | +481,458 | $970.3K | $3.18M | 3.20% | +$2.21M |
| Ascendis Pharma A/SADR(ASND) | 21,000 | 22,976 | +1,976 | $3.14M | $3.16M | 3.18% | +$27.6K |
| Mereo BioPharma Group plcADS(MREO) | 1,260,700 | 779,308 | -481,392 | $5.18M | $2.73M | 2.74% | -$2.45M |
| Bright Minds Biosciences Inc.(DRUG) | 0 | 69,124 | +69,124 | $0 | $2.49M | 2.50% | +$2.49M |
| Terns Pharmaceuticals Inc | 487,000 | 447,500 | -39,500 | $4.06M | $2.48M | 2.49% | -$1.58M |
| Edgewise Therapeutics, Inc.(EWTX) | 63,000 | 87,658 | +24,658 | $1.68M | $2.34M | 2.35% | +$659.0K |
| Helix Acquisition Corp IiCL A | 180,945 | 180,945 | 0 | $1.89M | $1.90M | 1.91% | +$9.1K |
| Unicycive Therapeutics Inc | 1,979,199 | 2,303,000 | +323,801 | $807.3K | $1.83M | 1.84% | +$1.02M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 190,000 | 134,500 | -55,500 | $3.51M | $1.69M | 1.70% | -$1.82M |
| Liquidia Corporation(LQDA) | 73,500 | 137,709 | +64,209 | $735.0K | $1.62M | 1.63% | +$884.5K |
| Mersana Therapeutics Inc | 1,200,000 | 1,120,500 | -79,500 | $2.27M | $1.60M | 1.61% | -$665.7K |
| Taysha Gene Therapies, Inc.(TSHA) | 2,118,992 | 884,244 | -1,234,748 | $4.26M | $1.53M | 1.54% | -$2.73M |
| Tectonic Therapeutic, Inc.(TECX) | 13,700 | 33,008 | +19,308 | $415.1K | $1.52M | 1.53% | +$1.11M |
| Cidara Therapeutics Inc | 0 | 54,473 | +54,473 | $0 | $1.46M | 1.47% | +$1.46M |
| Newamsterdam Pharma Co Nv ORDINARY SHARES | 0 | 50,000 | +50,000 | $0 | $1.28M | 1.29% | +$1.28M |
| Zymeworks Inc.(ZYME) | 0 | 67,240 | +67,240 | $0 | $984.4K | 0.99% | +$984.4K |
| Eledon Pharmaceuticals, Inc.N A(ELDN) | 0 | 235,750 | +235,750 | $0 | $971.3K | 0.98% | +$971.3K |
| Verve Therapeutics Inc | 146,100 | 160,200 | +14,100 | $707.1K | $903.5K | 0.91% | +$196.4K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 25,100 | 21,000 | -4,100 | $1.39M | $883.5K | 0.89% | -$510.8K |
| Gilead Sciences, Inc.(GILD) | 19,500 | 9,150 | -10,350 | $1.63M | $845.2K | 0.85% | -$789.7K |
| Arcellx Inc COMMON STOCK | 62,100 | 10,743 | -51,357 | $5.19M | $823.9K | 0.83% | -$4.36M |
| Sangamo Therapeutics, Inc.(SGMOQ) | 0 | 740,000 | +740,000 | $0 | $754.8K | 0.76% | +$754.8K |
| Third Harmonic Bio Inc | 15,508 | 49,800 | +34,292 | $210.1K | $512.4K | 0.52% | +$302.3K |
| Artiva Biotherapeutics, Inc.(ARTV) | 44,000 | 44,000 | 0 | $679.8K | $443.5K | 0.45% | -$236.3K |
| Forte Biosciences Inc | 0 | 18,139 | +18,139 | $0 | $411.9K | 0.41% | +$411.9K |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 74,307 | +74,307 | $0 | $397.5K | 0.40% | +$397.5K |
| Celcuity Inc.(CELC) | 46,600 | 25,000 | -21,600 | $694.8K | $327.3K | 0.33% | -$367.6K |
| Rapport Therapeutics, Inc.(RAPP) | 17,600 | 16,400 | -1,200 | $360.4K | $290.9K | 0.29% | -$69.5K |
| Nuvation Bio Inc.W EXP 07 07 2027(NUVB) | 90,832 | 90,832 | 0 | $8.9K | $20.9K | 0.02% | +$12.0K |
| Acelyrin Inc | 364,000 | 0 | -364,000 | $1.79M | $0 | — | -$1.79M |
| Benitec Biopharma Inc.(BNTC) | 29,800 | 0 | -29,800 | $273.9K | $0 | — | -$273.9K |
| Climb Bio, Inc.(CLYM) | 54,000 | 0 | -54,000 | $274.9K | $0 | — | -$274.9K |
| COMPASS Pathways plcADS(CMPS) | 386,500 | 0 | -386,500 | $2.43M | $0 | — | -$2.43M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 18,500 | 0 | -18,500 | $381.7K | $0 | — | -$381.7K |
| Dyne Therapeutics, Inc.(DYN) | 46,200 | 0 | -46,200 | $1.66M | $0 | — | -$1.66M |
| Geron Corporation(GERN) | 154,900 | 0 | -154,900 | $703.2K | $0 | — | -$703.2K |
| Kura Oncology, Inc.(KURA) | 197,000 | 0 | -197,000 | $3.85M | $0 | — | -$3.85M |
| Cypherpunk Technologies Inc.(CYPH) | 120,500 | 0 | -120,500 | $309.7K | $0 | — | -$309.7K |
| Travere Therapeutics, Inc.(TVTX) | 19,000 | 0 | -19,000 | $265.8K | $0 | — | -$265.8K |